Cholestyramine Powder, For Suspension
Product Images NDC 72162-1505

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cholestyramine (NDC 72162-1505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Cholestyramine For Oral Suspension 1)

Chemical structure diagram showing the main polymeric groups of cholestyramine, the active ingredient in Cholestyramine powder for suspension. The diagram highlights the polymer's benzene ring groups and attached functional groups relevant to its composition.*

FDA Label Image

Label (Lbl721621505)

Cholestyramine for Oral Suspension, USP powder label showing a 4 g dosage strength. Label includes the NDC 72162-1505-2 and indicates the product is for oral use with a 210 g container size. Labeler Bryant Ranch Prepack and manufacturer Par Formulations Private Limited are noted. Storage instructions, warnings, and presence of aspartame and phenylalanine are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.